相关实验视频

Updated: Apr 30, 2026

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Computed Tomography-guided Time-domain Diffuse Fluorescence Tomography in Small Animals for Localization of Cancer Biomarkers

Published on: July 17, 2012

转位蛋白18 kDa (TSPO):对于固体癌症的图像导向手术来说,这是一个有前途的分子标

Hendris Wongso^1,2, Ahmad Kurniawan¹, Yanuar Setiadi³

¹Research Center for Radioisotope, Radiopharmaceutical, and Biodosimetry Technology, Research Organization for Nuclear Energy, National Research and Innovation Agency Republic of Indonesia, Puspiptek, Banten 15314, Indonesia.

Advanced pharmaceutical bulletin

|April 8, 2024

概括

转位蛋白18-kDa (TSPO) 在癌症的发展和进展中至关重要. 针对TSPO的混合探针显示出作为改善癌症手术结果的外科导航器的前景.

科学领域:

生物化学生物化学
在瘤学瘤学.
医疗成像医学成像

背景情况:

转位蛋白18-kDa (TSPO),也称为外周二胺受体 (PBR),是一种线粒体蛋白质,涉及到许多细胞过程.
在各种癌症中,TSPO被上调,与侵略性表型和不良预后相关.
它在致癌过程中的作用使其成为诊断和预后工具的潜在目标.

研究的目的:

审查TSPO在致癌过程中的参与.
探索TSPO向混合探针在图像导向癌症手术中的潜力.

主要方法:

关于TSPO在癌症中的功能研究的文献综述.
分析TSPO准成像探测器的最新进展,包括放射性体和混合探测器.
评估用于图像引导手术应用的混合探针.

主要成果:

TSPO在类固醇生成,胆固醇运输,细胞存活,增殖和致癌过程中发挥着重要作用.
在各种癌症中,TSPO表达升高,与攻击性有关.
结合放射性和光分子的混合探针显示出对图像引导手术的前景.

结论:

TSPO是癌症发展和进展的关键参与者.
针对TSPO的混合探针为图像引导的癌症手术提供了一个有希望的方法.
这些探针的进一步开发可以提高外科导航和患者的治疗结果.

关键词:

癌症癌症癌症癌症图像引导手术是指导图像的手术.分子点是分子点.转位蛋白 18-kDa (TSPO) 是一种转位蛋白.

更多相关视频

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Harnessing the Bioorthogonal Inverse Electron Demand Diels-Alder Cycloaddition for Pretargeted PET Imaging

Published on: February 3, 2015

相关概念视频

Positron Emission Tomography

Positron Emission Tomography

Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...